Medicine policy is a critical determinant of pharmaceutical sector performance and healthcare access. East African nations have undertaken substantial policy reforms, creating a relevant repository of experience. Namibia shares comparable healthcare challenges and developmental goals with these nations, making their policy landscape a pertinent subject for analysis. This study aimed to critically analyse medicine policies implemented in East Africa to identify key lessons. Its primary objective was to derive specific, actionable implications for strengthening Namibia's pharmaceutical sector and guiding its future policy direction. A qualitative critical review methodology was employed. A systematic search and analysis of published policy documents, legislative frameworks, grey literature, and evaluation reports from East African countries was conducted. Data were thematically analysed to synthesise core policy trends and outcomes. The analysis identified improved medicine access following policy shifts towards robust national essential medicines lists and pooled procurement mechanisms. Policies fostering local pharmaceutical production were linked with enhanced supply security, though their success was often contingent on sustained governmental support and regional collaboration. East Africa's medicine policy evolution offers crucial insights for Namibia. The experiences demonstrate that strategic policy interventions can improve medicine availability and sector resilience, but require long-term commitment and adaptive implementation. It is recommended that Namibia considers adopting a formalised essential medicines list, explores regional procurement partnerships, and develops a supportive policy framework to incentivise sustainable local pharmaceutical manufacturing. health policy, pharmaceuticals, essential medicines, procurement, Namibia, East Africa, sector development This research provides a structured analysis of East African medicine policy from a Namibian perspective, offering evidence-based recommendations to inform national policy discourse and strategic planning.
Hamunyela et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: